Aug 7, 2026 08:35AM
Jun 4, 2026 08:41AM
Jun 4, 2026 08:40AM
Jun 1, 2026 09:03AM
Jun 1, 2026 09:02AM
May 13, 2026 08:05AM
Apr 22, 2026 09:00AM Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
Mar 13, 2026 08:00AM
Dec 11, 2025 05:00PM
Nov 19, 2025 08:45AM
Nov 19, 2025 08:45AM
Nov 13, 2025 08:45AM
Oct 10, 2025 09:31AM
Oct 10, 2025 09:30AM Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
Aug 13, 2025 08:00AM
Jul 30, 2025 09:01AM
Jul 30, 2025 09:00AM
Jul 23, 2025 08:33AM
Jul 23, 2025 08:30AM
Jul 8, 2025 09:00AM
May 14, 2025 08:05AM Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 10, 2025 06:38AM
Apr 9, 2025 09:15AM
Mar 26, 2025 09:03AM
Mar 26, 2025 09:00AM
Mar 19, 2025 08:05AM
Mar 13, 2025 08:30AM
Feb 27, 2025 09:15AM Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
Dec 17, 2024 09:15AM
Dec 16, 2024 09:00AM
Dec 6, 2024 06:50AM
Dec 5, 2024 08:47AM
Dec 5, 2024 08:45AM
Nov 22, 2024 09:15AM
Nov 21, 2024 08:30AM Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
Nov 13, 2024 08:30AM
Nov 12, 2024 09:00AM
Nov 7, 2024 09:00AM
Oct 22, 2024 08:45AM
Oct 21, 2024 05:08PM
Oct 17, 2024 08:47AM
Oct 17, 2024 08:30AM Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform
Sep 11, 2024 09:00AM
Aug 20, 2024 06:41AM
Aug 14, 2024 08:00AM

459,163 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All